Login / Signup

Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs.

Sean E HulseboschJully PiresMichael J BannaschThomas LancasterAndrea DelperoRamya RagupathySylaja MurikipudiTodd ZionChen Gilor
Published in: Journal of veterinary internal medicine (2022)
Control of clinical signs, body weight, and maintenance of glycemia was achieved with this once-weekly novel insulin construct in 4 of 5 dogs.
Keyphrases
  • body weight
  • type diabetes
  • glycemic control
  • high resolution
  • metabolic syndrome
  • combination therapy
  • skeletal muscle